MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial-Reference-Cited by-同舟云学术

MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial

Published:2022-07 Issue:1 Volume:304 Page:174-182
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Rodriguez Daniel^ORCID,Calmon Raphael,Aliaga Esther Sanchez,Warren Daniel,Warmuth-Metz Monika^ORCID,Jones Chris^ORCID,Mackay Alan,Varlet Pascale^ORCID,Le Deley Marie-Cécile^ORCID,Hargrave Darren^ORCID,Cañete Adela^ORCID,Massimino Maura^ORCID,Azizi Amedeo A.^ORCID,Saran Frank,Zahlmann Gudrun^ORCID,Garcia Josep^ORCID,Vassal Gilles,Grill Jacques^ORCID,Peet Andrew^ORCID,Dineen Robert A.^ORCID,Morgan Paul S.^ORCID,Jaspan Timothy^ORCID

Funder

F. Hoffman-La Roche

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.211464

Reference23 articles.

1. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management

2. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes

3. Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

4. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival;Neuroradiology;2024-07-16

2. Whole Spinal Cord FDG Uptake at PET/CT Caused by H3K27-Altered Diffuse Midline Glioma in an Adult Patient;Clinical Nuclear Medicine;2024-05-21

3. Advancements in Image-Based Models for High-Grade Gliomas Might Be Accelerated;Cancers;2024-04-19

4. Prognostic factors analysis of diffuse midline glioma;Journal of Neuro-Oncology;2024-02-21

5. Advances in Treatment of Diffuse Midline Gliomas;Current Neurology and Neuroscience Reports;2023-11-03